Mrugala MM - Search Results

1

Extended survival of glioblastoma patients after chemoprotective HSC gene therapy.

Adair JE, Beard BC, Trobridge GD, Neff T, Rockhill JK, Silbergeld DL, Mrugala MM, Kiem HP. Adair JE, et al. Among authors: mrugala mm. Sci Transl Med. 2012 May 9;4(133):133ra57. doi: 10.1126/scitranslmed.3003425. Sci Transl Med. 2012. PMID: 22572881 Free PMC article.

2

Evaluating the Patient with Neurotoxicity after Chimeric Antigen Receptor T-cell Therapy.

Fortin Ensign SP, Gaulin C, Hrachova M, Ruff M, Harahsheh E, Vicenti K, Castro J, Munoz J, Rosenthal A, Mrugala MM. Fortin Ensign SP, et al. Among authors: mrugala mm. Curr Treat Options Oncol. 2022 Dec;23(12):1845-1860. doi: 10.1007/s11864-022-01035-2. Epub 2022 Dec 16. Curr Treat Options Oncol. 2022. PMID: 36525238 Review.

3

Intracranial meningiomas: an overview of diagnosis and treatment.

Rockhill J, Mrugala M, Chamberlain MC. Rockhill J, et al. Neurosurg Focus. 2007;23(4):E1. doi: 10.3171/FOC-07/10/E1. Neurosurg Focus. 2007. PMID: 17961033 Review.

4

Mechanisms of disease: temozolomide and glioblastoma--look to the future.

Mrugala MM, Chamberlain MC. Mrugala MM, et al. Nat Clin Pract Oncol. 2008 Aug;5(8):476-86. doi: 10.1038/ncponc1155. Epub 2008 Jun 10. Nat Clin Pract Oncol. 2008. PMID: 18542116 Review.

5

Prognostic significance of growth kinetics in newly diagnosed glioblastomas revealed by combining serial imaging with a novel biomathematical model.

Wang CH, Rockhill JK, Mrugala M, Peacock DL, Lai A, Jusenius K, Wardlaw JM, Cloughesy T, Spence AM, Rockne R, Alvord EC Jr, Swanson KR. Wang CH, et al. Cancer Res. 2009 Dec 1;69(23):9133-40. doi: 10.1158/0008-5472.CAN-08-3863. Epub 2009 Nov 24. Cancer Res. 2009. PMID: 19934335 Free PMC article.

6

Temozolomide: Expanding its role in brain cancer.

Mrugala MM, Adair J, Kiem HP. Mrugala MM, et al. Drugs Today (Barc). 2010 Nov;46(11):833-46. doi: 10.1358/dot.2010.46.11.1549024. Drugs Today (Barc). 2010. PMID: 21225022 Review.

7

Outside the box--novel therapeutic strategies for glioblastoma.

Mrugala MM, Adair JE, Kiem HP. Mrugala MM, et al. Cancer J. 2012 Jan-Feb;18(1):51-8. doi: 10.1097/PPO.0b013e318243f785. Cancer J. 2012. PMID: 22290258 Review.

8

Discriminating survival outcomes in patients with glioblastoma using a simulation-based, patient-specific response metric.

Neal ML, Trister AD, Cloke T, Sodt R, Ahn S, Baldock AL, Bridge CA, Lai A, Cloughesy TF, Mrugala MM, Rockhill JK, Rockne RC, Swanson KR. Neal ML, et al. Among authors: mrugala mm. PLoS One. 2013;8(1):e51951. doi: 10.1371/journal.pone.0051951. Epub 2013 Jan 23. PLoS One. 2013. PMID: 23372647 Free PMC article.

9

Response classification based on a minimal model of glioblastoma growth is prognostic for clinical outcomes and distinguishes progression from pseudoprogression.

Neal ML, Trister AD, Ahn S, Baldock A, Bridge CA, Guyman L, Lange J, Sodt R, Cloke T, Lai A, Cloughesy TF, Mrugala MM, Rockhill JK, Rockne RC, Swanson KR. Neal ML, et al. Among authors: mrugala mm. Cancer Res. 2013 May 15;73(10):2976-86. doi: 10.1158/0008-5472.CAN-12-3588. Epub 2013 Feb 11. Cancer Res. 2013. PMID: 23400596 Free PMC article.

10

Advances and challenges in the treatment of glioblastoma: a clinician's perspective.

Mrugala MM. Mrugala MM. Discov Med. 2013 Apr;15(83):221-30. Discov Med. 2013. PMID: 23636139 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

101 results

Search Page

Filters